pharmaceuticals

Sanofi Headquarters

Pharmaceutical company Sanofi has presented strong results for the first quarter of 2022. Sales grew by around 13 percent to 9.7 billion euros. Exchange rate fluctuations had a positive impact, mainly due to the dollar. Overall, the French company benefited from good business with its neurodermatitis and asthma drug...

The equipment in small series production adapts to the project

Pharma and medical technology specialist Gerresheimer has established small series production at its Technical Competence Center at its Peachtree City, Georgia location. Small quantities of products can now be manufactured under series conditions and in ISO class 8 cleanroom. During the development and approval of...

New premises support Tower’s continuing growth

Located close to its existing premises in Theale, just 30 minutes from London Heathrow Airport, the 26,000 sq ft building will greatly expand Tower’s container conditioning and storage capacities, as well as enhancing its design, laboratory and testing capabilities in the development of robust, reliable and reusable...

Medical cannabis

Igea Pharma announced revenue expectations over the next three years of CHF 264 million globally, with an expected EBITDA margin in excess of 50 percent and expected net results of CHF 126 million of the joint venture the group will operate in the cannabis oil (CBD) market following the combination with Blue Sky...

Only an hour’s drive from Vetter’s headquarters in Ravensburg, Germany, the new site is well-positioned to become a successful expansion of Vetter’s existing clinical operations

A growing number of pharmaceutical and biotech companies are seeking clinical manufacturing partners that provide strategic support and comprehensive resources for their development process of new, promising injectable drug products. Vetter, a leading global Contract Development and Manufacturing Organization (CDMO)...

The credit outlook for the pharmaceutical sector in 2020 remains stable

The credit outlook for the pharmaceutical sector in 2020 remains stable. Successful innovation is underpinning strong growth in an industry which benefits from powerful secular trends - ageing populations and more affluent lifestyles. Scope Ratings says that some potential threats to the industry’s growth are also...